Blackhill Capital’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$763K Hold
3,400
0.04% 31
2025
Q4
$819K Hold
3,400
0.04% 29
2025
Q3
$931K Hold
3,400
0.05% 29
2025
Q2
$877K Hold
3,400
0.05% 28
2025
Q1
$761K Hold
3,400
0.04% 32
2024
Q4
$778K Hold
3,400
0.04% 30
2024
Q3
$830K Hold
3,400
0.05% 34
2024
Q2
$651K Hold
3,400
0.04% 34
2024
Q1
$673K Hold
3,400
0.04% 34
2023
Q4
$585K Hold
3,400
0.05% 33
2023
Q3
$503K Sell
3,400
-3,400
-50% -$615K 0.05% 32
2023
Q2
$1.49M Hold
6,800
0.16% 26
2023
Q1
$1.49M Hold
6,800
0.17% 28
2022
Q4
$1.42M Hold
6,800
0.16% 27
2022
Q3
$1.48M Sell
6,800
-400
-6% -$91K 0.18% 29
2022
Q2
$1.51M Hold
7,200
0.17% 30
2022
Q1
$1.75M Hold
7,200
0.17% 30
2021
Q4
$1.88M Hold
7,200
0.16% 29
2021
Q3
$1.9M Hold
7,200
0.16% 29
2021
Q2
$1.77M Hold
7,200
0.16% 29
2021
Q1
$1.4M Hold
7,200
0.12% 29
2020
Q4
$1.53M Hold
7,200
0.18% 29
2020
Q3
$1.23M Buy
7,200
+1,000
+16% +$185K 0.17% 29
2020
Q2
$1.19M Hold
6,200
0.18% 31
2020
Q1
$913K Hold
6,200
0.19% 33
2019
Q4
$961K Hold
6,200
0.14% 37
2019
Q3
$838K Buy
6,200
+700
+13% +$91.7K 0.13% 41
2019
Q2
$671K Hold
5,500
0.11% 43
2019
Q1
$572K Hold
5,500
0.1% 44
2018
Q4
$626K Sell
5,500
-500
-8% -$53.6K 0.12% 39
2018
Q3
$692K Buy
+6,000
New +$657K 0.11% 42

Other funds holding RMD

Blackhill Capital's RMD Position: Q1 2026 in Review

Blackhill Capital held its ResMed (RMD) position steady in Q1 2026 at 3,400 shares worth $763K. The position accounts for 0.04% of the portfolio, ranked #31.

Blackhill Capital first reported a position in RMD in Q3 2018 and has held it in 31 quarters since. The position peaked at $1.9M in Q3 2021. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Blackhill Capital held 3,400 shares of ResMed worth $763K as of Q1 2026.
  • Blackhill Capital left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.04% of Blackhill Capital's portfolio in Q1 2026, its #31 holding.
  • Blackhill Capital first reported a position in ResMed in Q3 2018 and has held it in 31 quarters since.
  • Blackhill Capital's ResMed position peaked at $1.9M in Q3 2021.
  • 940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Blackhill Capital's 13F filing for Q1 2026, filed 14 May 2026.